DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Labs) & by Region - Forecast to 2020" report to their offering.
The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. The U.S. in vitro diagnostics market is estimated to reach USD 25.99 Billion by 2020, growing at a CAGR of 4.7% during the forecast period.
This research report categorizes the U.S. IVD market on the basis of products & services, technologies, applications, and end users. These markets are further segmented, providing value analysis for 2013, 2014, and 2015, as well as forecast up to 2020. The end user market is comprehensively analyzed by region (South, Midwest, West, and Northeast) to provide in-depth information on the U.S. scenario.
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Johnson and Johnson
- Qiagen N.V.
- Roche Diagnostics
- Siemens Healthcare
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 U.S. in Vitro Diagnostics Market, By Product & Service
7 U.S. in Vitro Diagnostics Market, By Technology
8 U.S. in Vitro Diagnostics Market, By Application
9 U.S. in Vitro Diagnostics Market, By End User
10 Competitive Landscape
11 Company Profiles
For more information visit http://www.researchandmarkets.com/research/vw7wjx/u_s_in_vitro